The Supreme Court of the United States granted Dr. George Naum’s petition, vacated the Fourth Circuit’s judgment, and remanded the case in light of Ruan in 2022.
Some defense victories end a case. Others restore a legal question that the lower courts refused to recognize. Ron Chapman’s work for Dr. George Naum belongs in the second category.
Dr. Naum was convicted of participating in a conspiracy and aiding and abetting unlawful Suboxone distribution through Advance Healthcare in West Virginia. At the time, courts often evaluated a prescriber’s conduct through an objective lens: whether prescriptions fell outside professional practice, sometimes with little room for a physician’s honest belief or subjective intent. That approach risked turning a medical-standard dispute into a felony without requiring the jury to find that the physician knew or intended to act without authorization.
The central appellate strategy was therefore larger than any one chart. The defense preserved a mens rea argument: when a registered physician is authorized to prescribe controlled substances, the government should have to prove that the physician knowingly or intentionally crossed the line into unauthorized conduct. Negligence, regulatory error, or even objectively bad medicine is not automatically drug trafficking.
While Dr. Naum’s case was being pursued, the same issue reached the Supreme Court in Ruan v. United States. The Court held that once a defendant produces evidence that his or her conduct was “authorized,” the government must prove beyond a reasonable doubt that the defendant knowingly or intentionally acted in an unauthorized manner. The Supreme Court’s opinion in Ruan transformed the legal landscape for registered prescribers.
Ron Chapman, as counsel of record, petitioned the Supreme Court in Dr. Naum’s case. On June 30, 2022, the Court granted the petition, vacated the judgment, and remanded for further consideration in light of Ruan. The order and filing history appear on the Supreme Court docket for Naum v. United States.
That three-part order—grant, vacate, remand, commonly called a GVR—was vital for Dr. Naum’s case and others. The Supreme Court erased the appellate judgment then in place and directed the lower court to reconsider the case under the newly clarified law. Obtaining that relief requires issue preservation, a certiorari petition that connects the record to the developing Supreme Court question, and persistence after ordinary appellate avenues have narrowed.
On remand, the defense argued that the jury had not been properly instructed on subjective knowledge. The Fourth Circuit eventually agreed that the instructions misstated the post-Ruan law.
The lasting lesson of Naum is that the correct legal theory must be developed early and preserved precisely. A favorable Supreme Court decision may not help if the trial record triggers a more restrictive standard of appellate review.
For physicians under investigation, the strategic point is immediate. The defense should separate professional disagreement from criminal intent from the start. Jury instructions should focus on what the physician actually knew and intended. Good-faith evidence should be tied to the statutory authorization issue. Objections should be made clearly enough to preserve full appellate review.
Naum demonstrates the value of appellate counsel who can see a case not only as a closed record, but as part of a changing national legal question. It also offers a candid reminder: a GVR is a real Supreme Court victory, but it is an opportunity for reconsideration—not a promise of reversal.
Past results do not guarantee or predict a similar outcome. Every case depends upon its individual facts and circumstances.